SEC EDGAR · company profile · free

BRISTOL MYERS SQUIBB CO due diligence

Who BRISTOL MYERS SQUIBB CO (BMY) is on the public record: identity, annual results, what it filed in the last year and why, straight from SEC EDGAR.

1001 filings in EDGAR's recent index, 618 of them Form 4 insider filings · view the filings on SEC EDGAR · source: SEC EDGAR submissions index and XBRL financial data

At a glance

BRISTOL MYERS SQUIBB CO (BMY, CELG-RI) is a large accelerated filer incorporated in Delaware, classified under SIC 2834 (Pharmaceutical Preparations), and lists on NYSE. Its fiscal year ends December 31.

For the fiscal year ended December 31, 2025, its 10-K reported revenue of $48.2B, down 0.2% from the year before, net income of $7.1B, and total assets of $90.0B.

In the twelve months to October 9, 2026 it made 97 filings on EDGAR, including 1 annual report, 3 quarterly reports, 9 current reports on Form 8-K, and 62 Form 4 insider filings, plus 3 prospectus supplements and free writing prospectuses for its securities offerings. Its 8-Ks were filed most often for Regulation FD disclosures (5), results of operations (4), and other events (3).

CIK
0000014272
Filer status
Large accelerated filer
Industry (SIC)
Pharmaceutical Preparations (2834)
Incorporated
Delaware
Listed on
NYSE
Tickers
BMY, CELG-RI
Fiscal year end
12-31

Annual results

Fiscal year endedRevenueNet incomeTotal assets
2025-12-31$48.2B -0.2%$7.1B +178.8%$90.0B
2024-12-31$48.3B +7.3%-$8.9B -211.5%$92.6B
2023-12-31$45.0B$8.0B$95.2B
As reported in each 10-K's XBRL data on SEC EDGAR (revenue tag Revenues); a later 10-K's restatement replaces the earlier figure.
FilingFiledPeriodAccession
Annual report (10-K)2026-02-112025-12-310000014272-26-000004
Quarterly report (10-Q)2026-07-302026-06-300000014272-26-000020
Current report (8-K)2026-07-302026-07-300000014272-26-000018

Filing activity

97 filings since 2025-10-09, 3 of them prospectus supplements and free writing prospectuses (not listed below). By form:

4
62
8-K
9
10-Q
3
11-K
3
144
3
DEFA14A
2
SCHEDULE 13G
2
SCHEDULE 13G/A
2

8-K items in the last 12 months: Regulation FD disclosures (Item 7.01, 5) · results of operations (Item 2.02, 4) · other events (Item 8.01, 3) · shareholder vote results (Item 5.07, 1).

FiledFormDocumentPeriod
2026-10-054FORM 42026-10-02
2026-10-024FORM 42026-09-30
2026-10-024FORM 42026-09-30
2026-10-024FORM 42026-09-30
2026-10-024FORM 42026-09-30
2026-10-024FORM 42026-09-30
2026-09-104FORM 42026-09-09
2026-09-09144Form 144 notice of proposed sale
2026-09-034FORM 42026-09-01
2026-08-264FORM 42026-08-25
free alert

Free. One email a day at most, only when something changes. Confirm by email first; unsubscribe with one click. Privacy.

The full due-diligence dossier on BRISTOL MYERS SQUIBB CO

The free view above is identity and filing dates. The paid dossier reads the filings: business and segments, financial trend, insider and institutional activity, litigation and risk-factor themes, recent news, and the red flags, every claim cited and delivered with a data appendix.

agents: POST /v1/dossier with {"ticker":"BMY"} over x402 or MPP, $0.85

Sample output and API docs · all reports

BMY insider filingsAll company profiles13F fund holdingsAll reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.